Ocular Therapeutix, Inc. (OCUL) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ocular Therapeutix, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.069 -- 00:00:02.211 Please stand by, your program is about to begin. 00:00:02.211 -- 00:00:08.254 If you need assistance on today's program, please press star zero. 00:00:09.496 -- 00:00:14.940 Good morning and welcome to the Ocular Therapeutics second quarter 2024 earnings 00:00:14.940 -- 00:00:19.964 conference call. At this time, all participants are in a listen-only mode. 00:00:19.964 -- 00:00:24.007 After the prepared remarks, we will conduct a question and answer session. 00:00:24.007 -- 00:00:29.190 To ask a question, please press star one. As a reminder, this conference call 00:00:29.190 -- 00:00:33.912 is being recorded. will be available for replay on the investor relations section of 00:00:33.912 -- 00:00:37.075 the ocular therapeutics website 00:00:37.075 -- 00:00:41.417 i would now like to turn the call over to ocular's vice president of investor relations 00:00:41.417 -- 00:00:45.699 bill slattery please go ahead mr slattery 00:00:46.221 -- 00:00:50.704 good morning everyone and thank you for joining us today earlier this morning we issued 00:00:50.704 -- 00:00:55.547 a press release outlining our financial results for the second quarter 2024. 00:00:55.547 -- 00:00:57.483 make the best use of your time today 00:00:57.483 -- 00:01:01.067 Oculus Executive Chairman, President, and CEO, Dr. 00:01:01.067 -- 00:01:05.631 Praveen Dougal, will briefly provide a summary of recent business highlights so we can 00:01:05.631 -- 00:01:08.274 quickly get to your questions. Joining Dr. 00:01:08.274 -- 00:01:13.339 Dougal for the Q&A portion of the call will be Donald Notman, Chief Financial Officer, 00:01:13.339 -- 00:01:16.662 Dr. Nadia Waheed, Chief Medical Officer, Dr. 00:01:16.662 -- 00:01:22.947 Sanjay Nayak, Chief Strategy Officer, and Steve Myer...